biomarkers

You have access
High RRM1 Expression Is Associated with Adverse Outcome in Patients with Cisplatin/Vinorelbine-treated Malignant Pleural Mesothelioma
ZARAH GLAD ZIMLING, ERIC SANTONI-RUGIU, CECILIA BECH and JENS BENN SØRENSEN

Anticancer Research December 2015, 35 (12) 6731-6738;
You have access
Assessing Response to New Treatments and Prognosis in Melanoma Patients, by the Biomarker S-100β
VIVIAN BARAK, VERA LEIBOVICI, TAMAR PERETZ, INA KALICHMAN, MICHAL LOTEM and SHARON MERIMS

Anticancer Research December 2015, 35 (12) 6755-6760;
You have access
Biomarker Analysis in a Phase II Study of Sunitinib in Patients with Advanced Melanoma
LORE DECOSTER, ISABELLE VANDE BROEK, BART NEYNS, FRANÇOISE MAJOIS, JEAN FRANÇOIS BAURAIN, SYLVIE ROTTEY, ANDRÉE RORIVE, ELLEN ANCKAERT, JOHAN DE MEY, SYLVIA DE BRAKELEER and JACQUES DE GRÈVE

Anticancer Research December 2015, 35 (12) 6893-6899;
You have access
Extracellular Vesicles as Biomarkers and Therapeutic Targets in Breast Cancer
LILITE SADOVSKA, JĀNIS EGLĪTIS and AIJA LINĒ

Anticancer Research December 2015, 35 (12) 6379-6390;
You have access
Tissue Biomarkers in Predicting Response to Sunitinib Treatment of Metastatic Renal Cell Carcinoma
IVAN TRÁVNÍČEK, JINDŘICH BRANŽOVSKÝ, KRISTÝNA KALUSOVÁ, ONDŘEJ HES, LUBOŠ HOLUBEC, KEVIN BAULETH PELE, TOMÁŠ ÜRGE and MILAN HORA

Anticancer Research October 2015, 35 (10) 5661-5666;
You have access
Detection of Circulating Tumor Cells in Locally Advanced High-risk Prostate Cancer During Neoadjuvant Chemotherapy and Radical Prostatectomy
MARK THALGOTT, BRIGITTE RACK, THOMAS HORN, MATTHIAS M. HECK, MATTHIAS EIBER, HUBERT KÜBLER, MARGITTA RETZ, JÜRGEN E. GSCHWEND, ULRICH ANDERGASSEN and ROMAN NAWROTH

Anticancer Research October 2015, 35 (10) 5679-5685;
You have access
The Role of Methylation in Breast Cancer Susceptibility and Treatment
MARIE-CHRISTINE POULIOT, YVAN LABRIE, CAROLINE DIORIO and FRANCINE DUROCHER

Anticancer Research September 2015, 35 (9) 4569-4574;
You have access
Plasma TIMP-1 and CEA as Markers for Detection of Primary Colorectal Cancer: A Prospective Validation Study Including Symptomatic and Non-symptomatic Individuals
IB JARLE CHRISTENSEN, NILS BRÜNNER, BARRY DOWELL, GERARD DAVIS, HANS JØRGEN NIELSEN, GRAHAM NEWSTEAD and DENIS KING

Anticancer Research September 2015, 35 (9) 4935-4941;
You have access
Gene Expression Analysis for Evaluation of Potential Biomarkers in Hepatocellular Carcinoma
HOLGER HASS, JUERGEN JOBST, MICHAEL SCHEURLEN, ULRICH VOGEL and OLIVER NEHLS

Anticancer Research April 2015, 35 (4) 2021-2028;
You have access
Aberrant P53 Expression Lacks Prognostic or Predictive Significance in Colorectal Cancer: Results from the VICTOR Trial
MEGAN J. MCGREGOR, WAKKAS FADHIL, ROSE WHARTON, YOKO YANAGISAWA, MICHAEL PRESZ, ALISON PRITCHARD, CHRIS WOMACK, SUSAN DUTTON, RACHEL S. KERR, DAVID J. KERR, ELAINE C. JOHNSTONE and MOHAMMAD ILYAS

Anticancer Research March 2015, 35 (3) 1641-1645;

Main menu

User menu

Search

biomarkers

Pages